These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27527548)

  • 1. Local Side Effects of Sublingual and Oral Immunotherapy.
    Passalacqua G; Nowak-Węgrzyn A; Canonica GW
    J Allergy Clin Immunol Pract; 2017; 5(1):13-21. PubMed ID: 27527548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
    Scurlock AM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States.
    Epstein TG; Calabria C; Cox LS; Dreborg S
    J Allergy Clin Immunol Pract; 2017; 5(1):34-40.e2. PubMed ID: 27815065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language.
    Passalacqua G; Baena-Cagnani CE; Bousquet J; Canonica GW; Casale TB; Cox L; Durham SR; Larenas-Linnemann D; Ledford D; Pawankar R; Potter P; Rosario N; Wallace D; Lockey RF
    J Allergy Clin Immunol; 2013 Jul; 132(1):93-8. PubMed ID: 23683513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
    Cavaliere C; Incorvaia C; Begvarfaj E; Orlando MP; Turchetta R; Musacchio A; Ralli M; Ciofalo A; Greco A; de Vincentiis M; Masieri S
    Expert Opin Drug Saf; 2021 Mar; 20(3):259-264. PubMed ID: 33427529
    [No Abstract]   [Full Text] [Related]  

  • 6. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional Therapies for the Treatment of Food Allergy.
    Parrish CP; Kim EH; Bird JA
    Immunol Allergy Clin North Am; 2018 Feb; 38(1):77-88. PubMed ID: 29132676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Effectiveness of Bypassing Oral Immunotherapy Buildup With an Initial Phase of Sublingual Immunotherapy for Higher-Risk Food Allergy.
    Soller L; Williams BA; Mak R; Wong T; Erdle SC; Chomyn A; Tetreault B; Morrison K; Gaudet L; Chan ES
    J Allergy Clin Immunol Pract; 2024 May; 12(5):1283-1296.e2. PubMed ID: 38423293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy for food allergy and its future directions.
    Schworer SA; Kim EH
    Immunotherapy; 2020 Aug; 12(12):921-931. PubMed ID: 32611211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Calderon MA; Bernstein DI; Roberts G; Azuma R; Juhl RG; Hulstrøm V
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):85-95.e4. PubMed ID: 37972922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual Immunotherapy for the Polyallergic Patient.
    Pepper AN; Calderón MA; Casale TB
    J Allergy Clin Immunol Pract; 2017; 5(1):41-45. PubMed ID: 27452888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
    Moingeon P; Mascarell L
    Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and sublingual immunotherapy for food allergy.
    Nowak-Wegrzyn A; Sato S; Fiocchi A; Ebisawa M
    Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):606-613. PubMed ID: 31524655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic perspectives in food allergy.
    Marcucci F; Isidori C; Argentiero A; Neglia C; Esposito S
    J Transl Med; 2020 Aug; 18(1):302. PubMed ID: 32758254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Treatment of Food Allergy: Sublingual and Epicutaneous Immunotherapy.
    Sindher S; Fleischer DM; Spergel JM
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):39-54. PubMed ID: 26617226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet.
    Nolte H; Bernstein DI; Sussman GL; Svanholm Fogh B; Lu S; Husøy B; Nelson HS
    J Allergy Clin Immunol Pract; 2018; 6(6):2081-2086.e1. PubMed ID: 29432959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy.
    McGowan EC; Wood RA
    Curr Allergy Asthma Rep; 2014 Dec; 14(12):486. PubMed ID: 25297805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allergen-specific immunotherapy for food allergies in childhood. Current options and future perspectives].
    Trendelenburg V; Blümchen K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jul; 59(7):855-64. PubMed ID: 27324376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of sublingual immunotherapy in children.
    Frati F; Ridolo E; Fuiano N; Barberi S; Dell'Albani I; Landi M; Ricciardi L; Scala G; Incorvaia C
    Expert Opin Drug Saf; 2014 Jul; 13(7):947-53. PubMed ID: 24821477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.